首页 | 本学科首页   官方微博 | 高级检索  
     


Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein
Authors:Larry M. Gordon  Andy B. Lee  Piotr Ruchala  Alan J. Waring  Patrick W. Mobley
Affiliation:a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA
b Department of Biological Sciences, California State Polytechnic University, Pomona, CA, USA
c Chemistry Department, California State Polytechnic University, Pomona, 3801 West Temple Avenue, Pomona CA 91768, USA
d Department of Medicine, UCLA School of Medicine, Los Angeles, CA, USA
Abstract:Given their high alanine and glycine levels, plaque formation, α-helix to β-sheet interconversion and fusogenicity, FP (i.e., the N-terminal fusion peptide of HIV-1 gp41; 23 residues) and amyloids were proposed as belonging to the same protein superfamily. Here, we further test whether FP may exhibit ‘amyloid-like’ characteristics, by contrasting its structural and functional properties with those of Aβ(26-42), a 17-residue peptide from the C-terminus of the amyloid-beta protein responsible for Alzheimer's. FTIR spectroscopy, electron microscopy, light scattering and predicted amyloid structure aggregation (PASTA) indicated that aqueous FP and Aβ(26-42) formed similar networked β-sheet fibrils, although the FP fibril interactions were weaker. FP and Aβ(26-42) both lysed and aggregated human erythrocytes, with the hemolysis-onsets correlated with the conversion of α-helix to β-sheet for each peptide in liposomes. Congo red (CR), a marker of amyloid plaques in situ, similarly inhibited either FP- or Aβ(26-42)-induced hemolysis, and surface plasmon resonance indicated that this may be due to direct CR-peptide binding. These findings suggest that membrane-bound β-sheets of FP may contribute to the cytopathicity of HIV in vivo through an amyloid-type mechanism, and support the classification of HIV-1 FP as an ‘amyloid homolog’ (or ‘amylog’).
Keywords:HIV-1, Human Immunodeficiency Virus, Type 1   HIV-2, Human Immunodeficiency Virus, Type 2   gp41, glycoprotein 41,000 of HIV-1   FP, fusion peptide (23-residues) at the N-terminus of HIV-1 gp41 (LAV1a strain)   SIV, simian immunodeficiency virus   gp32, glycoprotein 32,000 of HIV-2/SIV   Aβ, amyloid-beta protein   Aβ(1-40) or Aβ(1-42), amyloid-beta protein residues 1-40 or 1-42   Aβ(26-42), C-terminal peptide 26-42 of amyloid-beta protein   DLS, dynamic light scattering   TEM, transmission electron microscopy   PIRA, parallel β-sheet, in register arrangement   PASTA, prediction of amyloid structure aggregation   PBS, phosphate-buffered saline, Phosphate buffer, 10   mM sodium phosphate buffer, pH 7.4   HBS-EP buffer, 10   mM Hepes, pH 7.4, 150   mM NaCl, 3   mM EDTA, 0.005%, surfactant P20   DMSO, dimethyl sulfoxide   HFIP, hexafluoroisopropanol   SDS, sodium dodecyl sulfate   TFE, trifluoroethanol   RBC, red blood cells   POPG, 1-palmitoyl-2-oleoyl phosphatidylglycerol   LUV, large unilamellar vesicles   POPC, 1-palmitoyl-2-oleoylphosphatidylcholine   POPG, 1-palmitoyl-2-oleoylphosphatidylglycerol   P/L, peptide/lipid molar ratio   CD, circular dichroism   FTIR, Fourier transform infrared   ATR, attenuated-total-reflectance   2D-NMR, two dimensional Nuclear Magnetic Resonance   IR50, inhibitory ratio (IR) of the agent concentration to that the membrane-active agent that induces 50% inhibition   IR100, inhibitory ratio (IR) of the agent concentration to that the membrane-active agent that induces 100% inhibition   ID50, inhibitor concentration that yields 50% inhibition for a stated dose of membrane-active agent   PrP, prion protein   HPrP, human prion protein   BPrP, bovine prion protein   MD, molecular dynamics   SPR, surface plasmon resonance   CR, Congo red
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号